Entod Pharmaceuticals to release eye drop for myopia in children, with CDSCO approval, advanced trials, and market potential.

A dropless regimen for cataract surgery had similar inflammation rates as standard of care, according to a study presented at ...

CDSCO granted marketing authorisation following the successful completion of a Phase 3 clinical trial conducted across 11 ...